Back to Search
Start Over
High proportion of tumor necrosis predicts poor survival in surgically resected high-grade neuroendocrine carcinoma of the lung
- Source :
- Lung cancer (Amsterdam, Netherlands). 157
- Publication Year :
- 2021
-
Abstract
- Tumor necrosis is a negative prognostic factor in various cancers. High-grade neuroendocrine carcinomas (HGNEC) of the lung, such as small cell lung cancer (SCLC) and large cell neuroendocrine carcinoma (LCNEC), commonly have histopathological features of tumor necrosis. However, the prognostic value of tumor necrosis remains unknown.A total of 81 patients with HGNEC (SCLC, n = 42; LCNEC, n = 39) who underwent complete resection were enrolled. The proportion of necrosis in the tumor tissues was quantified using digital image analysis. We analyzed the relationship between the proportion of necrosis, clinicopathological factors, and prognosis. Moreover, we examined the correlation between genomic alterations and proportion of necrosis.The median proportion of necrosis was 10.6 % (range, 0-62.8 %). The proportion of necrosis was not significantly different between SCLC (median, 5.1 %; range, 0-62.8 %) and LCNEC (median: 14.2 %; range, 0-59.3 %) (p = 0.14). The cumulative incidence of recurrence (CIR) and lung cancer-specific cumulative incidence of death (LC-CID) were significantly higher in patients with 10 % or higher necrosis (necrosis ≥ 10 %) than in those with less than 10 % (necrosis10 %) (hazard ratio [HR], 2.94; 95 % confidence interval [CI], 1.30-6.64, and HR, 2.87; 95 % CI, 1.13-7.29, respectively). In the bivariate analysis, necrosis ≥ 10 % was independently associated with higher CIR and tended to be associated with higher LC-CID. The frequency of genomic alterations in the PI3K/AKT/mTOR pathway, MYC family, MAPK/ERK pathway, and major RTK signaling pathways were not different between the necrosis ≥ 10 % and necrosis10 % groups for both SCLC and LCNEC.High proportion of tumor necrosis (≥ 10 %) had a negative prognostic value in surgically resected HGNEC.
- Subjects :
- 0301 basic medicine
Pulmonary and Respiratory Medicine
Cancer Research
medicine.medical_specialty
Necrosis
Lung Neoplasms
Complete resection
Gastroenterology
03 medical and health sciences
0302 clinical medicine
Internal medicine
medicine
Humans
Neuroendocrine carcinoma
In patient
Cumulative incidence
Large-cell neuroendocrine carcinoma
Lung
business.industry
Prognosis
Carcinoma, Neuroendocrine
030104 developmental biology
medicine.anatomical_structure
Oncology
030220 oncology & carcinogenesis
Carcinoma, Large Cell
Tumor necrosis factor alpha
medicine.symptom
Neoplasm Recurrence, Local
business
Subjects
Details
- ISSN :
- 18728332
- Volume :
- 157
- Database :
- OpenAIRE
- Journal :
- Lung cancer (Amsterdam, Netherlands)
- Accession number :
- edsair.doi.dedup.....372b1d27ec7b790ef2f1b2bc18be75f4